1Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arteriosclerosis Thrombosis and Vascular Biology 1999; 19 (4): 972–978.
2Bullo M, Garcia-Lorda P, Megias I, Salas-Salvado J. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obesity Research 2003; 11 (4): 525–531.
3Horowitz JF, Coppack SW, Paramore D, Cryer PE, Zhao G, Klein S. Effect of short-term fasting on lipid kinetics in lean and obese women. American Journal of Physiology 1999; 276 (2 Pt 1): E278–E284.
4Samad F, Yamamoto K, Loskutoff DJ. Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide. Journal of Clinical Investigation 1996; 97 (1): 37–46.
5Samad F, Pandey M, Loskutoff DJ. Tissue factor gene expression in the adipose tissues of obese mice. Proceedings of the National Academic of Science USA 1998; 95 (13): 7591–7596.
6De Pergola G, Pannacciulli N. Coagulation and fibrinolysis abnormalities in obesity. Journal of Endocrinology Investigation 2002; 25 (10): 899–904.
7Perreault M, Marette A. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nature Medicine 2001; 7 (10): 1138–1143.
8Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. Journal of Clinical Endocrinology and Metabolism 1998; 83 (3): 847–850.
9Bullo M, Garcia-Lorda P, Peinado-Onsurbe J, Hernandez M, Del Castillo D, Argiles JM, et al. . TNFalpha expression of subcutaneous adipose tissue in obese and morbid obese females: relationship to adipocyte LPL activity and leptin synthesis. International Journal of Obesity and Related Metabolic Disorders 2002; 26 (5): 652–658.
10Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, JrFerrante AW. Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 2003; 112 (12): 1796–1808.
11Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, et al. . Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. Journal of Lipid Research 2005; 46 (11): 2347–2355.
12Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C, et al. . Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005; 54 (8): 2277–2286.
13Stallone DD. The influence of obesity and its treatment on the immune system. Nutrition Reviews 1994; 52 (2 Pt 1): 37–50.
14Cousin B, Munoz O, Andre M, Fontanilles AM, Dani C, Cousin JL, et al. . A role for preadipocytes as macrophage-like cells. FASEB Journal 1999; 13 (2): 305–312.
15Charriere G, Cousin B, Arnaud E, Andre M, Bacou F, Penicaud L, et al. . Preadipocyte conversion to macrophage. Evidence of plasticity. Journal of Biological Chemistry 2003; 278 (11): 9850–9855.
16Zhang B, Berger J, Hu E, Szalkowski D, White-Carrington S, Spiegelman BM, et al. . Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha. Molecular Endocrinology 1996; 10 (11): 1457–1466.
17Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, et al. . Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of Clinical Investigation 2003; 112 (12): 1821–1830.
18Curat CA, Miranville A, Sengenes C, Diehl M, Tonus C, Busse R, et al. . From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 2004; 53 (5): 1285–1292.
19Lacasa D, Taleb S, Keophiphath M, Miranville A, Clement K. Macrophage-secreted factors impair human adipogenesis: involvement of proinflammatory state in preadipocytes. Endocrinology 2006; 148 (2): 868–877. November 2 [Epub ahead of print].
20Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37 (12): 1595–1607.
21Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000; 101 (18): 2149–2153.
22Souza SC, Palmer HJ, Kang YH, Yamamoto MT, Muliro KV, Paulson KE, et al. . TNF-alpha induction of lipolysis is mediated through activation of the extracellular signal related kinase pathway in 3T3-L1 adipocytes. Journal of Cellular Biochemistry 2003; 89 (6): 1077–1086.
23Bullo-Bonet M, Garcia-Lorda P, Lopez-Soriano FJ, Argiles JM, Salas-Salvado J. Tumour necrosis factor, a key role in obesity? FEBS Letter 1999; 451 (3): 215–219.
24Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. American Journal of Physiology, Endocrinology and Metabolism 2001; 280 (5): E745–E751.
25van Hall G, Steensberg A, Sacchetti M, Fischer C, Keller C, Schjerling P, et al. . Interleukin-6 stimulates lipolysis and fat oxidation in humans. Journal of Clinical Endocrinology and Metabolism 2003; 88 (7): 3005–3010.
26Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Journal of the American Medical Association 2001; 286 (3): 327–334.
27Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000; 101 (18): 2149–2153.
28Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. New England Journal of Medicine 1999; 340 (6): 448–454.
29Torres JL, Ridker PM. Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events. Current Opinion in Cardiology 2003; 18 (6): 471–478.
30Dixon JB, O’Brien PE. Obesity and the white blood cell count: changes with sustained weight loss. Obesity Surgery 2006; 16 (3):
31Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. . Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysics Research Communication 1999; 257 (1): 79–83.
32Bulló M, Salas-Salvado J, Garcia-Lorda P. Adiponectin expression and adipose tissue lipolytic activity in lean and obese women. Obesity Surgery 2005; 15 (3): 382–386.
33Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. . Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis, Thrombosis and Vascular Biology 2000; 20 (6): 1595–1599.
34Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Current Opinión in Lipidology 2003; 14 (6): 561–566.
35Tomas E, Tsao TS, Saha AK, Murrey HE, Zhang Cc C, Itani SI, et al. . Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proceedings of the National Academic of Science USA 2002; 99 (25): 16309–16313.
36Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. British Medical Journal (Clinical Research Ed) 1984; 288 (6428): 1401–1404.
37Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, et al. . PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001; 50 (9): 2094–2099.
38Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Letter 2006; 580 (12): 2917–2921.
39Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, et al. . Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005; 307 (5708): 426–430.
40Hammarstedt A, Pihlajamaki J, Rotter Sopasakis V, Gogg S, Jansson PA, Laakso M, et al. . Visfatin is an adipokine, but it is not regulated by thiazolidinediones. Journal of Clinical Endocrinology and Metabolism 2006; 91 (3): 1181–1184.
41Chen MP, Chung FM, Chang DM, Tsai JC, Huang HF, Shin SJ, et al. . Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 2006; 91 (1): 295–299.
42Fleischmann E, Kurz A, Niedermayr M, Schebesta K, Kimberger O, Sessler DI, et al. . Tissue oxygenation in obese and non-obese patients during laparoscopy. Obesity Surgery 2005; 15 (6): 813–819.
43Kabon B, Nagele A, Reddy D, Eagon C, Fleshman JW, Sessler DI, et al. . Obesity decreases perioperative tissue oxygenation. Anesthesiology 2004; 100 (2): 274–280.
44Lolmede K, Durand de Saint Front V, Galitzky J, Lafontan M, Bouloumie A. Effects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442A adipocytes. International Journal of Obesity and Related Metabolic Disorders 2003; 27 (10): 1187–1195.
45Segawa K, Fukuhara A, Hosogai N, Morita K, Okuno Y, Tanaka M, et al. . Visfatin in adipocytes is upregulated by hypoxia through HIF1alpha-dependent mechanism. Biochemistry and Biophysics Research Communication 2006; 349 (3): 875–882.
46Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, et al. . Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. Journal of the American Medical Association 2003; 289 (14): 1799–1804.
47Troseid M, Lappegard KT, Claudi T, Damas JK, Morkrid L, Brendberg R, et al. . Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome. European Heart Journal 2004; 25 (4): 349–355.
48Haider DG, Schindler K, Schaller G, Prager G, Wolzt M, Ludvik B. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. Journal of Clinical Endocrinology and Metabolism 2006; 91 (4): 1578–1581.
49Bastard JP, Hainque B, Dusserre E, Bruckert E, Robin D, Vallier P, et al. . Peroxisome proliferator activated receptor-gamma, leptin and tumor necrosis factor-alpha mRNA expression during very low calorie diet in subcutaneous adipose tissue in obese women. Diabetes and Metabolism Research Review 1999; 15 (2): 92–98.
50Viguerie N, Vidal H, Arner P, Holst C, Verdich C, Avizou S, et al. . Adipose tissue gene expression in obese subjects during low-fat and high-fat hypocaloric diets. Diabetologia 2005; 48 (1): 123–131.
51 Salas-Salvado J, Bullo M, Garcia-Lorda P, Figueredo R, Del Castillo D, Bonada A, et al. Subcutaneous adipose tissue cytokine production is not responsible for the restoration of systemic inflammation markers during weight loss. International Journal of Obesity (London) 2006; 30 (12): 1714–1720.
52Murdoch C, Giannoudis A, Lewis CE. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 2004; 104 (8): 2224–2234.
53Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. British Journal of Nutrition 2004; 92 (3): 347–355.
54Ridker PM. High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit. American Heart Journal 2004; 148 (Suppl. 1): S19–S26.
55Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, et al. . Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. British Medical Journal 2000; 321 (7255): 199–204.
56Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. . C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New England Journal of Medicine 2004; 350 (14): 1387–1397.
57Zhao G, Etherton TD, Martin KR, Vanden Heuvel JP, Gillies PJ, West SG, et al. . Anti-inflammatory effects of polyunsaturated fatty acids in THP-1 cells. Biochemical Biophysics Research Communication 2005; 336 (3): 909–917.
58Miles EA, Zoubouli P, Calder PC. Differential anti-inflammatory effects of phenolic compounds from extra virgin olive oil identified in human whole blood cultures. Nutrition 2005; 21 (3): 389–394.
59Manna SK, Mukhopadhyay A, Aggarwal BB. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. Journal of Immunology 2000; 164 (12): 6509–6519.
60Giugliano D, Marfella R, Coppola L, Verrazzo G, Acampora R, Giunta R, et al. . Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation 1997; 95 (7): 1783–1790.
61Giugliano D, Ceriello A, Esposito K. The effects of diet on inflammation: emphasis on the metabolic syndrome. Journal of American College of Cardiology 2006; 48 (4): 677–685.
62Qi L, Meigs JB, Liu S, Manson JE, Mantzoros C, Hu FB. Dietary fibers and glycemic load, obesity, and plasma adiponectin levels in women with type 2 diabetes. Diabetes Care 2006; 29 (7): 1501–1505.
63Ma Y, Griffith JA, Chasan-Taber L, Olendzki BC, Jackson E, 3rdStanek EJ, et al. . Association between dietary fiber and serum C-reactive protein. American Journal of Clinical Nutrition 2006; 83 (4): 760–766.
64Ajani UA, Ford ES, Mokdad AL. Dietary fiber and C-reactive protein findings from Nacional Health Nutrition Examination Survey data. Journal of Nutrition 2004; 134: 1181–1185.
65Liu S, Buring JE, Sesso HD, Rimm EB, Willett WC, Manson JE. A prospective study of dietary fiber intake and risk of cardiovascular disease among women. Journal of American Collage of Cardiology 2002; 39 (1): 49–56.
Pereira MA, Kroenke CH, Hilner JE, Van Horn L, Slattery ML, et al. . Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults. Journal of the American Medical Association 1999; 282 (16): 1539–1546.
67Pereira MA, O’Reilly E, Augustsson K, Fraser GE, Goldbourt U, Heitmann BL, et al. . Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Archives of Internal Medicine 2004; 164 (4): 370–376.
68Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Willett WC, Rimm EB. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003; 108 (2): 155–160.
69Lopez-Garcia E, Schulze MB, Manson JE, Meigs JB, Albert CM, Rifai N, et al. . Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. Journal of Nutrition 2004; 134 (7): 1806–1811.
70Zampelas A, Panagiotakos DB, Pitsavos C, Das UN, Chrysohoou C, Skoumas Y, et al. . Fish consumption among healthy adults is associated with decreased levels of inflammatory markers related to cardiovascular disease: the ATTICA study. Journal of American College of Cardiology 2005; 46 (1): 120–124.
71Madsen T, Skou HA, Hansen VE, Fog L, Christensen JH, Toft E, et al. . C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease. American Journal of Cardiology 2001; 88 (10): 1139–1142.
72Ciubotaru I, Lee YS, Wander RC. Dietary fish oil decreases C-reactive protein, interleukin-6, and triacylglycerol to HDL-cholesterol ratio in postmenopausal women on HRT. Journal of Nutrition Biochem 2003; 14 (9): 513–521.
73Rallidis LS, Paschos G, Liakos GK, Velissaridou AH, Anastasiadis G, Zampelas A. Dietary alpha-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis 2003; 167 (2): 237–242.
74Bemelmans WJ, Lefrandt JD, Feskens EJ, van Haelst PL, Broer J, Meyboom-de Jong B, et al. . Increased alpha-linolenic acid intake lowers C-reactive protein, but has no effect on markers of atherosclerosis. European Journal of Clinical Nutrition 2004; 58 (7): 1083–1089.
75Zhao G, Etherton TD, Martin KR, West SG, Gillies PJ, Kris-Etherton PM. Dietary alpha-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. Journal of Nutrition 2004; 134 (11): 2991–2997.
76Lopez-Garcia E, Schulze MB, Meigs JB, Manson JE, Rifai N, Stampfer MJ, et al. . Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. Journal of Nutrition 2005; 135 (3): 562–566.
77Baer DJ, Judd JT, Clevidence BA, Tracy RP. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. American Journal of Clinical Nutrition 2004; 79 (6): 969–973.
78Lichtenstein AH, Erkkila AT, Lamarche B, Schwab US, Jalbert SM, Ausman LM. Influence of hydrogenated fat and butter on CVD risk factors: remnant-like particles, glucose and insulin, blood pressure and C-reactive protein. Atherosclerosis 2003; 171 (1): 97–107.
79Perez-Jimenez F, Alvarez de Cienfuegos G, Badimon L, Barja G, Battino M, Blanco A, et al. . International conference on the healthy effect of virgin olive oil. European Journal of Clinical Investigation 2005; 35 (7): 421–424.
80Fito M, Cladellas M, de la Torre R, Marti J, Alcantara M, Pujadas-Bastardes M, et al. . Antioxidant effect of virgin olive oil in patients with stable coronary heart disease: a randomized, crossover, controlled, clinical trial. Atherosclerosis 2005; 181 (1): 149–158.
81Martinez-Dominguez E, de la Puerta R, Ruiz-Gutierrez V. Protective effects upon experimental inflammation models of a polyphenol-supplemented virgin olive oil diet. Inflammation Research 2001; 50 (2): 102–106.
82Carluccio MA, Siculella L, Ancora MA, Massaro M, Scoditti E, Storelli C, et al. . Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of mediterranean diet phytochemicals. Arteriosclerosis, Thrombosis and Vascular Biology 2003; 23 (4): 622–629.
83Kris-Etherton PM, Yu-Poth S, Sabate J, Ratcliffe HE, Zhao G, Etherton TD. Nuts and their bioactive constituents: effects on serum lipids and other factors that affect disease risk. American Journal of Clinical Nutrition 1999; 70 (Suppl. 3): 504S–511S.
84Salas-Salvado J, Bullo M, Perez-Heras A, Ros E. Dietary fibre, nuts and cardiovascular diseases. British Journal of Nutrition 2006; 96 (Suppl. 2): S45–S51.
85Halvorsen BL, Holte K, Myhrstad MC, Barikmo I, Hvattum E, Remberg SF, et al. . A systematic screening of total antioxidants in dietary plants. Journal of Nutrition 2002; 132 (3): 461–471.
86Cooke JP, Tsao P, Singer A, Wang BY, Kosek J, Drexler H. Anti-atherogenic effect of nuts: is the answer NO? Archives of Internal Medicine 1993; 153 (7): 896–902.
87Fitzpatrick DF, Hirschfield SL, Ricci T, Jantzen P, Coffey RG. Endothelium-dependent vasorelaxation caused by various plant extracts. Journal of Cardiovascular Pharmacology 1995; 26 (1): 90–95.
Exler J, Weihrauch JL. Provisional tables on the content of omega-3 fatty acids and other fat components of selected foods. Journal of American Dietetic Association 1986; 86 (6): 788–793.
89Zwarts L, Savage GP, McNeil DL. Fatty acid content of new zealand-grown walnuts (juglans regia L.). International Journal of Food Science Nutrition 1999; 50 (3): 189–194.
90Jiang R, JrJacobs DR, Mayer-Davis E, Szklo M, Herrington D, Jenny NS, et al. . Nut and seed consumption and inflammatory markers in the multi-ethnic study of atherosclerosis. American Journal of Epidemiology 2006; 163 (3): 222–231.
91Ros E, Nunez I, Perez-Heras A, Serra M, Gilabert R, Casals E, et al. . A walnut diet improves endothelial function in hypercholesterolemic subjects: a randomized crossover trial. Circulation 2004; 109 (13): 1609–1614.
92Nash SD, Westpfal M. Cardiovascular benefits of nuts. American Journal of Cardiology 2005; 95 (8): 963–965.
93He FJ, Nowson CA, MacGregor GA. Fruit and vegetable consumption and stroke: meta-analysis of cohort studies. Lancet 2006; 367 (9507): 320–326.
94van Herpen-Broekmans WM, Klopping-Ketelaars IA, Bots ML, Kluft C, Princen H, Hendriks HF, et al. . Serum carotenoids and vitamins in relation to markers of endothelial function and inflammation. European Journal of Epidemiology 2004; 19 (10): 915–921.
95Watzl B, Kulling SE, Moseneder J, Barth SW, Bub A. A 4-wk intervention with high intake of carotenoid-rich vegetables and fruit reduces plasma C-reactive protein in healthy, nonsmoking men. American Journal of Clinical Nutrition 2005; 82 (5): 1052–1058.
96Devaraj S, Jialal I. Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients. Free Radical Biology and Medicine 2000; 29 (8): 790–792.
97Sanchez-Moreno C, Cano MP, de Ancos B, Plaza L, Olmedilla B, Granado F, et al. . High-pressurized orange juice consumption affects plasma vitamin C, antioxidative status and inflammatory markers in healthy humans. Journal of Nutrition 2003; 133 (7): 2204–2209.
98Estruch R, Sacanella E, Badia E, Antunez E, Nicolas JM, Fernandez-Sola J, et al. . Different effects of red wine and gin consumption on inflammatory biomarkers of atherosclerosis: a prospective randomized crossover trial. Effects of wine on inflammatory markers. Atherosclerosis 2004; 175 (1): 117–123.
99Albert MA, Glynn RJ, Ridker PM. Alcohol consumption and plasma concentration of C-reactive protein. Circulation 2003; 107 (3): 443–447.
100Stewart SH, JrMainous AG, Gilbert G. Relation between alcohol consumption and C-reactive protein levels in the adult US population. Journal of the American Board of Family Practice 2002; 15 (6):
101Rahman I, Biswas SK, Kirkham PA. Regulation of inflammation and redox signaling by dietary polyphenols. Biochemical Pharmacology 2006; 72 (11): 1439–1452.
102Marier JF, Chen K, Prince P, Scott G, del Castillo JR, Vachon P. Production of ex vivo lipopolysaccharide-induced tumor necrosis factor-alpha, interleukin-1beta, and interleukin-6 is suppressed by trans-resveratrol in a concentration-dependent manner. Canadian Journal of Veterinary Research 2005; 69 (2): 151–154.
103Lotito SB, Frei B. Dietary flavonoids attenuate TNFalpha-induced adhesion molecule expression in human aortic endothelial cells: structure–function relationships and activity after first-pass metabolism. Journal of Biological Chemistry 2006 September 20 [Epub ahead of print].
104Rimm EB, Stampfer MJ. Wine, beer, and spirits: are they really horses of a different color? Circulation 2002; 105 (24): 2806–2807.
105Estruch R, Coca A, Rodicio JL. High blood pressure, alcohol and cardiovascular risk. Journal of Hypertension 2005; 23 (1): 226–229.
106Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. New England Journal of Medicine 2003; 348 (26): 2599–2608.
107Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, et al. . Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. Journal of the American Medical Association 2004; 292 (12): 1440–1446.
108Estruch R, Martinez-Gonzalez MA, Corella D, Salas-Salvado J, Ruiz-Gutierrez V, Covas MI, et al. . Effects of a mediterranean-style diet on cardiovascular risk factors: a randomized trial. Annals of Internal Medicine 2006; 145 (1): 1–11.
109Michalsen A, Lehmann N, Pithan C, Knoblauch NT, Moebus S, Kannenberg F, et al. . Mediterranean diet has no effect on markers of inflammation and metabolic risk factors in patients with coronary artery disease. European Journal of Clinical Nutrition 2006; 60 (4): 478–485.